You are here

congenital adrenal hyperplasia

Neurocrine’s hopes for hyperplasia blockbuster a step closer after phase 3 win

Neurocrine’s hopes for hyperplasia blockbuster a step closer after phase 3 win

Fierce Biotech

Neurocrine Biosciences

clinical trials

congenital adrenal hyperplasia

Flag link:

Spruce's Drug Candidate Reduces Elevated Hormones in Classic CAH Patients

Spruce's Drug Candidate Reduces Elevated Hormones in Classic CAH Patients

BioSpace

Spruce Biosciences

clinical trials

congenital adrenal hyperplasia

Flag link:

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

Xconomy

Spruce Biosciences

congenital adrenal hyperplasia

Flag link:

Armed with a batch of positive biomarker data, a rare disease player reaps $88M for the next big push in the clinic

Armed with a batch of positive biomarker data, a rare disease player reaps $88M for the next big push in the clinic

Endpoints

congenital adrenal hyperplasia

Flag link:

Neurocrine hits the brakes on its genetic disease drug

Neurocrine hits the brakes on its genetic disease drug

Fierce Biotech

congenital adrenal hyperplasia

Flag link: